These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24919418)

  • 21. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
    Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H
    PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
    Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
    Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans.
    Kiank C; Zeden JP; Drude S; Domanska G; Fusch G; Otten W; Schuett C
    PLoS One; 2010 Jul; 5(7):e11825. PubMed ID: 20689575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin.
    O'Connor JC; André C; Wang Y; Lawson MA; Szegedi SS; Lestage J; Castanon N; Kelley KW; Dantzer R
    J Neurosci; 2009 Apr; 29(13):4200-9. PubMed ID: 19339614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase.
    Lee J; Lee J; Park MK; Lim MA; Park EM; Kim EK; Yang EJ; Lee SY; Jhun JY; Park SH; Kim HY; Cho ML
    PLoS One; 2013; 8(4):e60900. PubMed ID: 23613752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
    Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
    Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy.
    Gomes B; Driessens G; Bartlett D; Cai D; Cauwenberghs S; Crosignani S; Dalvie D; Denies S; Dillon CP; Fantin VR; Guo J; Letellier MC; Li W; Maegley K; Marillier R; Miller N; Pirson R; Rabolli V; Ray C; Streiner N; Torti VR; Tsaparikos K; Van den Eynde BJ; Wythes M; Yao LC; Zheng X; Tumang J; Kraus M
    Mol Cancer Ther; 2018 Dec; 17(12):2530-2542. PubMed ID: 30232146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.
    Jackman KA; Brait VH; Wang Y; Maghzal GJ; Ball HJ; McKenzie G; De Silva TM; Stocker R; Sobey CG
    Naunyn Schmiedebergs Arch Pharmacol; 2011 May; 383(5):471-81. PubMed ID: 21359968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.
    Folgiero V; Goffredo BM; Filippini P; Masetti R; Bonanno G; Caruso R; Bertaina V; Mastronuzzi A; Gaspari S; Zecca M; Torelli GF; Testi AM; Pession A; Locatelli F; Rutella S
    Oncotarget; 2014 Apr; 5(8):2052-64. PubMed ID: 24903009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.
    Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X
    Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
    Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
    J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
    Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA
    Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology.
    El-Zaatari M; Chang YM; Zhang M; Franz M; Shreiner A; McDermott AJ; van der Sluijs KF; Lutter R; Grasberger H; Kamada N; Young VB; Huffnagle GB; Kao JY
    J Immunol; 2014 Jul; 193(2):807-16. PubMed ID: 24935925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IFN-γ-IDO1-kynureine pathway-induced autophagy in cervical cancer cell promotes phagocytosis of macrophage.
    Yang SL; Tan HX; Niu TT; Liu YK; Gu CJ; Li DJ; Li MQ; Wang HY
    Int J Biol Sci; 2021; 17(1):339-352. PubMed ID: 33390854
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of gene silencing of indoleamine 2,3-dioxygenase 1 combined with rosmarinic acid on tumor immune microenvironment in H22 tumor-bearing mice.
    Cao W; Pan J; Mo K; Wang Z; Wei S; Yin Y; Qin M; Zhang W
    Int Immunopharmacol; 2023 Jun; 119():110193. PubMed ID: 37062258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells.
    Ibana JA; Belland RJ; Zea AH; Schust DJ; Nagamatsu T; AbdelRahman YM; Tate DJ; Beatty WL; Aiyar AA; Quayle AJ
    Infect Immun; 2011 Nov; 79(11):4425-37. PubMed ID: 21911470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
    Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z
    Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Li A; Barsoumian HB; Schoenhals JE; Caetano MS; Wang X; Menon H; Valdecanas DR; Niknam S; Younes AI; Cortez MA; Welsh JW
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):903-912. PubMed ID: 30905636
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Bando H; Sakaguchi N; Lee Y; Pradipta A; Ma JS; Tanaka S; Lai DH; Liu J; Lun ZR; Nishikawa Y; Sasai M; Yamamoto M
    Front Immunol; 2018; 9():2073. PubMed ID: 30283439
    [No Abstract]   [Full Text] [Related]  

  • 40. Indoleamine 2,3-Dioxygenase Activity in
    Virok DP; Raffai T; Kókai D; Paróczai D; Bogdanov A; Veres G; Vécsei L; Poliska S; Tiszlavicz L; Somogyvári F; Endrész V; Burián K
    Front Cell Infect Microbiol; 2019; 9():192. PubMed ID: 31249813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.